The Vox Markets Podcast / Cathal Friel, Executive Chairman of Open Orphan talks about their £8.1m contract with a Major Global Pharma Company

View our embed guidelines

Sorry, your browser isn't supported.

We recommend upgrading to the latest Chrome, Firefox, Safari, or Edge.

You can visit our support center if you're having problems.